Bergan Kdv Wealth Management, LLC Sage Therapeutics, Inc. Transaction History

Bergan Kdv Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$37.06 - $47.11 $1,519 - $1,931	-41 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$40.26 - $57.37 $120 - $172	3 Added 7.89%	41 $2,000
Q2 2021 Aug 10, 2021	BUY	$54.88 - $79.29 $932 - $1,347	17 Added 80.95%	38 $2,000
Q2 2020 Aug 13, 2020	BUY	$25.95 - $43.15 $544 - $906	21 New	21 $1,000

200

46.5M

462K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $319M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.